期刊文献+

艾滋病病毒耐药性研究的概况及进展 被引量:10

The general situation and progress of research on HIV drug resistance
下载PDF
导出
摘要 由于高效抗逆转录药物治疗(HAART)的出现,使许多艾滋病病毒(HIV)感染的患者延长了生命,这无疑是HIV感染和艾滋病治疗史上一个重要的里程碑。但是HIV耐药性的出现,已经成为HAART失败最重要的原因之一。近些年,由于分子生物学技术的发展,人们已经能从分子和基因水平研究HIV耐药性的发生机制和检测方法。
作者 陈亮 吴南屏
出处 《国外医学(流行病学.传染病学分册)》 2005年第3期159-161,共3页 Epidemiology Lemology Foreign Medical Sciences
  • 相关文献

参考文献17

  • 1Huang H, Chopra R, Verdine GL, et al. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science, 1998,282(5394): 1669-1675.
  • 2Balzarini J. Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy. Biochem Pharmacol, 1999,58( 1 ): 1-27.
  • 3Fujiwara T, Sato A, el-Farrash M, et al. S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1. Antimicrob Agents Chemother, 1998,42(6): 1340-1345.
  • 4Mellors JW, Bazmi HZ, Schinazi RF, et al. Novel mutations in the reverse transcriptase of human immunodeficiency virus type 1 reduce susceptibility to foscarnet in laboratory and clinical isolates. Antimicrob Agents Chemother, 1995,39(5): 1087-1092.
  • 5Berkhout B. HIV-1 evolution under pressure of protease inhibitors:climbing the stairs of viral fitness. J Biomed Sci, 1999,6(5): 298-305.
  • 6Zhang YM, Imamichi H, Imamichi T, et al. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J Virol, 1997,71 (9): 6662-6670.
  • 7Shirasaka T, Kavlick MF, Ueno T, et al. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc Natl Acad Sci USA, 1995,92(6): 2398-2402.
  • 8Uhlmann EJ, Tebas P, Storch GA. Effects of the G190A substitution of HIV reverse transcriptase on henotypic susceptibility of patient isolates to delavirdine. J Clin Virol, 2004,31(3):198-203.
  • 9Barlow KL, Tatt ID, Cane PA, et al. Recombinant strains of HIV type 1 in the United Kingdom. AIDS Res Hum Retroviruses, 2001, 17(5):467-474.
  • 10Pillay D, Walker AS, Gibb DM, et al. Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial. J Infect Dis, 2002,186(5):617-625.

同被引文献118

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部